Article
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532
27 Oct 2004
Abstract excerpt
Telomerase represents an attractive target for a mechanism-based therapeutic approach because its activation has been associated with unlimited proliferation in most cancer cells. Recently, a nonnucleosidic small molecule inhibitor, BIBR1532 (2-[(E)-3-naphtalen-2-yl-but-2-enoylamino]-benzoic acid), has been identified that is highly selective for inhibition of telomerase, resulting in delayed growth arrest of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
